Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Zeltiq Aesthetics, MGH Initiate Patent Lawsuit Against Clinipro - Quick Facts

RELATED NEWS
Trade ZLTQ now with 
1/25/2012 7:23 AM ET

Medical technology company Zeltiq Aesthetics, Inc. (ZLTQ: Quote) and the charitable trust of Massachusetts General Hospital or MGH initiated a patient infringement lawsuit in France against Clinipro and its French representative.

In its suit, Zeltiq alleged infringement of a European patent for CoolSculpting technology owned by Massachusetts General Hospital and licensed to Zeltiq and sought monetary damages and an injunction against further sales of Clinipro's LipoCryo device. Zeltiq said the CoolSculpting technology is protected by numerous patents and trademarks around the world.

Click here to receive FREE breaking news email alerts for ZELTIQ Aesthetics, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Chipmaker Advanced Micro Devices Inc. said Thursday after the markets closed that its first quarter loss narrowed from last year, helped by strong revenue growth in its graphics and visual solutions business. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarterly revenue. After trending higher over the past few sessions, stocks showed a lack of direction throughout the trading day on Thursday. The major averages spent the session bouncing back and forth across the unchanged line before ending the day mixed. While the major averages closed on opposite sides of the unchanged line, they all showed only modest moves. U.S. Secretary Of State John Kerry said Thursday that he and his counterparts from Russia, Ukraine and the European Union have reached an agreement on a preliminary plan for ending the ongoing crisis in Ukraine. Kerry was speaking at the end of the Ukraine contact group's first meeting, comprising the foreign ministers of Russia, Ukraine, the EU and the U.S., in the Swiss city of Geneva.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.